Zimmer Gains Hedrocel Biomaterial Spinal Application Rights Via Implex
This article was originally published in The Gray Sheet
Executive Summary
Zimmer will develop fusion and non-fusion spinal devices using Implex' Hedrocel porous biomaterial, following acquisition of the company in Q1 2004